Jointly Drawing a New Blueprint for the Biopharmaceutical Industry: Zhongke Huirun Invited to Attend the Symposium on Promoting High-Quality Development of the Biopharmaceutical Industry in Xiong'an New Area
2025-11-19
Preface to the Meeting
As the Xiong'an New Area—a “millennial plan and national priority”—it is firmly anchored in its national mission of becoming a key hub for independent innovation and original innovation in the new era, and is making every effort to build itself into an international highland for innovation in the biopharmaceutical industry. On November 19, the High-Quality Development Promotion Conference for the Biopharmaceutical Industry in the Xiong'an New Area, together with the Key Institutions and Enterprises’ Xiong'an Visit event, was grandly held, bringing together at the national level leaders from various ministries and commissions, academicians from the two academies, medical institutions, and leading enterprises in the industry to jointly chart the course for industrial development.
Strategic anchor:
Xiong'an New Area: the core hub for innovative development of the national biopharmaceutical industry.
As a strategic initiative designated as a “millennial-scale plan and national priority,” the Xiong’an New Area is firmly committed to its national mission of becoming a key hub for independent innovation and original innovation in the new era, and is making every effort to develop the modern life sciences and biotechnology industries. This conference represents a crucial step in implementing the "Several Policy Measures to Support the High-Quality Development of the Biopharmaceutical Industry in Hebei’s Xiong’an New Area." Guided by national-level policies, the conference aims to attract global resources from industry, academia, research, and medicine, accelerate the establishment of a modern biopharmaceutical industrial system that embodies Xiong’an’s unique characteristics, leads the nation, and reaches international standards, and ultimately create the "Xiong’an Model" for innovative development of China’s biopharmaceutical industry.
As a leading enterprise in the high-end imaging industry with 12 years of deep expertise in conventional MRI technology, Zhongke Huirun has been invited to participate extensively in this industry event, joining forces with industry leaders from various sectors to jointly discuss the strategic development plan for the biomedical industry in the Xiong'an New Area and help bring the nation’s strategic initiatives to fruition.
Highlights of the Grand Event: Combining top-level design with precise matchmaking for a two-way synergy, jointly writing a new chapter for the industry.
At the high-quality promotion meeting held on the morning of November 19, Academician Xia Ningshao of the Chinese Academy of Engineering delivered a cutting-edge keynote speech, sharing global trends in life sciences and biotechnology innovation. Chen Ming, Director of the Pharmaceutical Development Division of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology, provided an insightful interpretation of the national “Several Policies to Support the High-Quality Development of the Biopharmaceutical Industry in Xiong’an New Area, Hebei Province.” Mei Xinyang, Member of the Party Working Committee and Deputy Director of the Management Committee of Xiong’an New Area, and Li Yue, Deputy Director of the Bureau of Industrial and Information Technology and Data, comprehensively outlined the strategic plan for industrial development in Xiong’an, demonstrating Xiong’an New Area’s determination and vision in building itself into a leading hub for the biopharmaceutical industry.
During the key “Xiong’an Visit” event held on the afternoon of November 19, Zhongke Huirun engaged in dialogues and deep-level exchanges with numerous senior executives, focusing on technology transfer in the medical-engineering interdisciplinary field and the widespread adoption of basic-level MRI. Together, they explored new scenario models for developing high-end imaging equipment to enhance primary healthcare services, identified innovative pathways for promoting healthcare access at the grassroots level, and contributed to Xiong’an’s efforts to create a model for Healthy China.
Jointly exploring new-quality productivity
 |
 |
Hui Ren Power: Leveraging advanced imaging technology and AI innovation to significantly enhance the quality of primary healthcare.
Leveraging this national-level event, Zhongke Huirun will precisely seize the policy benefits and strategic opportunities presented by the Xiong'an New Area, laying a solid foundation for the company’s long-term development in the New Area. At the same time, the company will fully harness its expertise in manufacturing high-end imaging equipment and Zhongke’s Dual Sync technology to inject “Zhongke Huirun Intelligence” into the high-quality development of Xiong'an’s biopharmaceutical industry, helping the New Area become a globally leading innovation hub for the biopharmaceutical industry.
A new journey, new responsibilities, a new mission.
Taking this conference as an opportunity, Zhongke Huirun will deeply integrate into the nation’s strategic framework, join hands with all relevant parties, and work together to propel the biomedical industry in the Xiong'an New Area toward leapfrog development, injecting a continuous stream of innovative momentum into the building of a Healthy China.
New opportunities, new calls, new actions.
In the future, Zhongke Huirun will deeply integrate into the nation’s strategic framework, leveraging its robust expertise in high-end imaging manufacturing and its cutting-edge AI innovation capabilities to foster even deeper integration with the Xiong’an industrial ecosystem. This will inject strong momentum into the leapfrog development of the新区’s biopharmaceutical industry and help propel China’s health initiative to new heights.
 |
 |
Recent News
Contact phone
Address: Building 4, Digital Industry Base, No. 555 Chuangzhi Road, Lianchi District, Baoding City, Hebei Province, China
Time: 8:00 a.m. - 12:00 p.m.; 2:00 p.m. - 5:30 p.m.